Sarepta Therapeutics, Inc.
SRPT • NASDAQ
Sarepta Therapeutics, Inc. is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Douglas S. Ingram, with a market cap of $2.2B.
Market Cap$2.2B
Employees1.3K
CEODouglas S. Ingram
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 6, 2026 · In 1 weekAfter Market Close · Q1 2026
Financials
Sarepta Therapeutics, Inc. FAQ
Common questions about Sarepta Therapeutics, Inc.
Sarepta Therapeutics, Inc. is scheduled to report earnings for Q1 2026 on May 6, 2026 after market close. Analysts estimate revenue of $474.2M.
Sarepta Therapeutics, Inc. has approximately 1,314 employees.